| About | Speakers | Followers | Exhibitors | Reviews |
Excited about the event? Spread the word and invite your network!
Share
Join us for the online conference 'From Omics to Action: NGS Proteomics at the Heart of Precision Medicine,' organized by Labroots. This insightful session will delve into how next-generation sequencing (NGS) proteomics is revolutionizing our understanding of health and disease, particularly in the context of precision medicine. Attendees will discover
...
the seamless integration of proteomics with other omics disciplines like genomics, metabolomics, and transcriptomics, which is critical for uncovering significant connections between environmental exposures, metabolic health, and disease outcomes.
The conference will feature two compelling case studies powered by Olink® Explore. The first study, 'PFAS Exposure and Sleep Disruption: The Role of Proteins,' investigates gene-disease associations by incorporating proteomics data into human and toxicological studies. It aims to provide fresh insights into the health risks associated with per- and polyfluoroalkyl substances (PFAS) exposure, particularly its impact on sleep disruptions in young adults through metabolic and immune pathways. This integrated approach combines human epidemiological studies with proteomics and toxicological data to identify potential biomarkers linked to PFAS-induced sleep disturbances.
The second study, 'Proteomics in Biomarker Discovery for Type 2 Diabetes Remission,' focuses on finding proteomic biomarkers in adolescents undergoing bariatric surgery for Type 2 diabetes (T2D) remission. By analyzing plasma samples collected before and after surgery, researchers have identified prognostic biomarkers that predict the likelihood of T2D remission five years post-surgery. This study leverages insights from the UK Biobank T2D study, offering a broader understanding that can inform actionable healthcare strategies.
Additionally, attendees will learn about how NGS proteomics technologies are driving biomarker discovery and their clinical applications. The importance of multiomics integration in advancing precision medicine will be highlighted, along with discussions on the enhancements in biomarker detection facilitated by prior research data. The event will also explore the future of proteomic analysis through single-molecule proteome analysis, addressing the limitations of current methodologies in terms of scale and resolution. Overall, this conference promises to be an enlightening exploration of how modern proteomics can accelerate discovery and development in the realm of personalized medicine.
The conference will feature two compelling case studies powered by Olink® Explore. The first study, 'PFAS Exposure and Sleep Disruption: The Role of Proteins,' investigates gene-disease associations by incorporating proteomics data into human and toxicological studies. It aims to provide fresh insights into the health risks associated with per- and polyfluoroalkyl substances (PFAS) exposure, particularly its impact on sleep disruptions in young adults through metabolic and immune pathways. This integrated approach combines human epidemiological studies with proteomics and toxicological data to identify potential biomarkers linked to PFAS-induced sleep disturbances.
The second study, 'Proteomics in Biomarker Discovery for Type 2 Diabetes Remission,' focuses on finding proteomic biomarkers in adolescents undergoing bariatric surgery for Type 2 diabetes (T2D) remission. By analyzing plasma samples collected before and after surgery, researchers have identified prognostic biomarkers that predict the likelihood of T2D remission five years post-surgery. This study leverages insights from the UK Biobank T2D study, offering a broader understanding that can inform actionable healthcare strategies.
Additionally, attendees will learn about how NGS proteomics technologies are driving biomarker discovery and their clinical applications. The importance of multiomics integration in advancing precision medicine will be highlighted, along with discussions on the enhancements in biomarker detection facilitated by prior research data. The event will also explore the future of proteomic analysis through single-molecule proteome analysis, addressing the limitations of current methodologies in terms of scale and resolution. Overall, this conference promises to be an enlightening exploration of how modern proteomics can accelerate discovery and development in the realm of personalized medicine.
Listed In
Excited about the event? Spread the word and invite your network!
Share
Timings09:00 AM-06:00 PM (expected)Not Verified | Entry FeesCheck Official Website |
Estimated Turnoutupto 100 Delegates | Event TypeConference |
EditionsMay 2025 InterestedFrequency Newly Listed | Official LinksWebsiteContacts Report Error Claim this event |
Organizer Queries about the event?
Ask Organizer
Labroots USA887 Total Events • 965 Followers | |
Near the venue with time to spare? New in town?
Invite others for coffee and plan your day!
EditionMay 2025
How would you like to participate in this event?
Visitor
Exhibitor
Speaker
Invite users with similar interest
Laurri Quaye Mensah Kassim
Grethel Wendy Ascher
Anna Valencia Hall
Sabine Akoury
Juliana Dias
omar kamal
Md.Ashrafuzzaman Hemel
Elsayed Elshamy
View More
https://10times.com/hub/wellness-healthcare-hub
Aug 182025
May 072025